<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-G6I3ERIZ</identifier><date>2004</date><creator>Trampuž, Andrej</creator><relation>documents/doc/G/URN_NBN_SI_doc-G6I3ERIZ_001.pdf</relation><relation>documents/doc/G/URN_NBN_SI_doc-G6I3ERIZ_001.txt</relation><format format_type="volume">73</format><format format_type="issue">7-8</format><format format_type="type">article</format><format format_type="extent">str. 617</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID_HOST">18351065</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-G6I3ERIZ</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">Drug Therapy</subject><subject language_type_id="slv">Etiology</subject><subject language_type_id="slv">Sepsa</subject><subject language_type_id="slv">Sepsis</subject><title>Odgovor na pismo prim. Marjete Škerl, dr. med., v zvezi s člankom "Novosti v patogenezi in zdravljenju sepse"</title></Record>